TY - JOUR
T1 - A mechanical turing machine
T2 - Blueprint for a biomolecular computer
AU - Shapiro, Ehud
N1 - [ERC-Adg233047]Mechanical design performed by K. Karunaratne from Korteks and M. Schilling from Schilling 3D Design Inc. I thank Avi Karni and Doron Lancet for helpful comments and discussions, and Rivka Adar and Tom Ran for help in preparing the paper. Ehud Shapiro is the incumbent of the Harry Weinrebe Professorial Chair of Computer Science and Biology. His research on Biomolecular Computing is supported by ERC-Adg233047.
PY - 2012/3/21
Y1 - 2012/3/21
N2 - We describe a working mechanical device that embodies the theoretical computing machine of Alan Turing, and as such is a universal programmable computer. The device operates on three-dimensional building blocks by applying mechanical analogues of polymer elongation, cleavage and ligation, movement along a polymer, and control by molecular recognition unleashing allosteric conformational changes. Logically, the device is not more complicated than biomolecular machines of the living cell, and all its operations are part of the standard repertoire of these machines; hence, a biomolecular embodiment of the device is not infeasible. If implemented, such a biomolecular device may operate in vivo, interacting with its biochemical environment in a program-controlled manner. In particular, it may 'compute' synthetic biopolymers and release them into its environment in response to input from the environment, a capability that may have broad pharmaceutical and biological applications.
AB - We describe a working mechanical device that embodies the theoretical computing machine of Alan Turing, and as such is a universal programmable computer. The device operates on three-dimensional building blocks by applying mechanical analogues of polymer elongation, cleavage and ligation, movement along a polymer, and control by molecular recognition unleashing allosteric conformational changes. Logically, the device is not more complicated than biomolecular machines of the living cell, and all its operations are part of the standard repertoire of these machines; hence, a biomolecular embodiment of the device is not infeasible. If implemented, such a biomolecular device may operate in vivo, interacting with its biochemical environment in a program-controlled manner. In particular, it may 'compute' synthetic biopolymers and release them into its environment in response to input from the environment, a capability that may have broad pharmaceutical and biological applications.
UR - http://www.scopus.com/inward/record.url?scp=84862671119&partnerID=8YFLogxK
U2 - https://doi.org/10.1098/rsfs.2011.0118
DO - https://doi.org/10.1098/rsfs.2011.0118
M3 - مقالة
SN - 2042-8898
VL - 2
SP - 497
EP - 503
JO - Interface Focus
JF - Interface Focus
IS - 4
ER -